Ostéonécrose maxillaire sous bisphosphonates et implants dentaires

Coleman, 2004, Bisphosphonates: clinical experience, Oncologist, 9, 14, 10.1634/theoncologist.9-90004-14 Marx, 2005, Bisphosphonates-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors? Recognition, prevention, and treatment, J. Oral Maxillofac. Surg., 63, 1567, 10.1016/j.joms.2005.07.010 Bamias, 2005, Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence risk factors, J. Clin. Oncol., 23, 8580, 10.1200/JCO.2005.02.8670 Hugentobler, 2006, Proposition d'un algorithme de prise en charge médicodentaire pour les patients traités par bisphosphonates, Rev. Stomatol. Chir. Maxillofac., 107, 441, 10.1016/S0035-1768(06)77084-X Meer, 2006, Mandibular osteomyelitis and tooth exfoliation following zoster-CMV co-infection, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 101, 70, 10.1016/j.tripleo.2005.06.022 Ruggiero, 2006, Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 102, 433, 10.1016/j.tripleo.2006.06.004 Woeller, 2006, Ostéonécrose des maxillaires sous bisphosphonates: cinq cas, Rev. Stomatol. Chir. Maxillofac., 107, 417, 10.1016/S0035-1768(06)77080-2 Garg, 2006, Bisphosphonates and avascular necrosis of alveolar bone: a potential threat to dental implants, Dent. Implantol. Update, 17, 73 Rodan, 1996, Bisphosphonates:mechanisms of action, J. Clin. Invest., 97, 2692, 10.1172/JCI118722 Mashiba, 2001, Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles, Bone, 28, 524, 10.1016/S8756-3282(01)00414-8